437 related articles for article (PubMed ID: 27350740)
1. Successful treatment of ileal ulcers caused by immunosuppressants in two organ transplant recipients.
Guo YW; Gu HY; Abassa KK; Lin XY; Wei XQ
World J Gastroenterol; 2016 Jun; 22(24):5616-22. PubMed ID: 27350740
[TBL] [Abstract][Full Text] [Related]
2. Terminal Ileac Ulcers Mimicked Post-transplantation Lymphoproliferative Disorder in a Heart Recipient Treated With Everolimus: A Case Report.
Iwasaki K; Seguchi O; Mochizuki H; Kimura Y; Toda K; Kumai Y; Kuroda K; Nakajima S; Watanabe T; Yanase M; Matsumoto Y; Fukushima S; Fujita T; Kobayashi J; Fukushima N
Transplant Proc; 2018 Dec; 50(10):4053-4056. PubMed ID: 30577313
[TBL] [Abstract][Full Text] [Related]
3. Oral ulcers in kidney transplant recipients treated with sirolimus and mycophenolate mofetil.
van Gelder T; ter Meulen CG; Hené R; Weimar W; Hoitsma A
Transplantation; 2003 Mar; 75(6):788-91. PubMed ID: 12660502
[TBL] [Abstract][Full Text] [Related]
4. Tacrolimus-Associated Terminal Ileitis After Kidney Transplantation, Mimicking Crohn Disease: A Case Report.
Collini A; Ongaro A; Favi E; Lazzi S; Micheletti G; Ruggieri G
Transplant Proc; 2024 Mar; 56(2):459-462. PubMed ID: 38368132
[TBL] [Abstract][Full Text] [Related]
5. Deep Ulcers in the Ileum Associated with Mycophenolate Mofetil.
Sonoda A; Wada K; Mizukami K; Fukuda K; Shuto M; Okamoto K; Ogawa R; Okimoto T; Murakami K
Intern Med; 2017 Nov; 56(21):2883-2886. PubMed ID: 28943566
[TBL] [Abstract][Full Text] [Related]
6. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
Gruessner RW
Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
[TBL] [Abstract][Full Text] [Related]
7. Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months.
Gonwa T; Mendez R; Yang HC; Weinstein S; Jensik S; Steinberg S;
Transplantation; 2003 Apr; 75(8):1213-20. PubMed ID: 12717205
[TBL] [Abstract][Full Text] [Related]
8. [Atypical cytomegalovirus in renal transplantation: a new form of presentation].
Pérez-Valentín MA; Cofán F; Solé M; Llach J; Esforzado N; Campistol JM; Oppenheimer F
Nefrologia; 2002; 22(4):381-5. PubMed ID: 12369131
[TBL] [Abstract][Full Text] [Related]
9. Sirolimus immunosuppression in pediatric heart transplant recipients: a single-center experience.
Lobach NE; Pollock-Barziv SM; West LJ; Dipchand AI
J Heart Lung Transplant; 2005 Feb; 24(2):184-9. PubMed ID: 15701435
[TBL] [Abstract][Full Text] [Related]
10. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
[TBL] [Abstract][Full Text] [Related]
11. Oral ulcerations as a sequela of tacrolimus and mycophenolate mofetil therapy.
Philipone E; Rockafellow A; Sternberg R; Yoon A; Koslovsky D
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Dec; 118(6):e175-8. PubMed ID: 25457894
[TBL] [Abstract][Full Text] [Related]
12. Unusual Cause of Small Intestinal Bleeding in a Renal Transplant Recipient.
Su HA; Hsu HT; Yen HH
Gastroenterology; 2017 Mar; 152(4):e13-e14. PubMed ID: 28161227
[No Abstract] [Full Text] [Related]
13. Inferior results with basis immunosuppression with sirolimus in kidney transplantation.
van den Akker JM; Hené RJ; Hoitsma AJ
Neth J Med; 2007 Jan; 65(1):23-8. PubMed ID: 17293636
[TBL] [Abstract][Full Text] [Related]
14. Sirolimus induced dyslipidemia in tacrolimus based vs. tacrolimus free immunosuppressive regimens in renal transplant recipients.
Hakeam HA; Al-Jedai AH; Raza SM; Hamawi K
Ann Transplant; 2008; 13(2):46-53. PubMed ID: 18566560
[TBL] [Abstract][Full Text] [Related]
15. A 12-month single arm pilot study to evaluate the efficacy and safety of sirolimus in combination with tacrolimus in kidney transplant recipients at high immunologic risk.
Lee J; Lee JJ; Kim BS; Lee JG; Huh KH; Park Y; Kim YS
J Korean Med Sci; 2015 Jun; 30(6):682-7. PubMed ID: 26028917
[TBL] [Abstract][Full Text] [Related]
16. Impact of sirolimus on the recurrence of hepatocellular carcinoma after liver transplantation.
Chinnakotla S; Davis GL; Vasani S; Kim P; Tomiyama K; Sanchez E; Onaca N; Goldstein R; Levy M; Klintmalm GB
Liver Transpl; 2009 Dec; 15(12):1834-42. PubMed ID: 19938137
[TBL] [Abstract][Full Text] [Related]
17. Time-Dependent and Immunosuppressive Drug-Associated Adverse Event Profiles in De Novo Kidney Transplant Recipients Converted from Tacrolimus to Sirolimus Regimens.
Felix MJ; Felipe CR; Tedesco-Silva H; Osmar Medina-Pestana J
Pharmacotherapy; 2016 Feb; 36(2):152-65. PubMed ID: 26799522
[TBL] [Abstract][Full Text] [Related]
18. Post-renal transplant hemolytic uremic syndrome following combination therapy with tacrolimus and everolimus.
Pratap B; Abraham G; Srinivas CN; Bhaskar S
Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):609-12. PubMed ID: 17951952
[TBL] [Abstract][Full Text] [Related]
19. Late-onset tacrolimus-associated cerebellar atrophia in a heart transplant recipient.
Kaczmarek I; Schmauss D; Sodian R; Beiras-Fernandez A; Oberhoffer M; Daebritz S; Schoenberg SO; Reichart B
J Heart Lung Transplant; 2007 Jan; 26(1):89-92. PubMed ID: 17234523
[TBL] [Abstract][Full Text] [Related]
20. Mycophenolate Mofetil-induced Oral Ulcerations in a Kidney Transplant Recipient.
Gaied H; Bacha MM; Mesbahi T; Ounissi M; Aoudia R; Jerbi M; Jones M; Ksantini M; Rammeh S; Hedri H; Goucha R; Abdallah TB
Curr Drug Saf; 2020; 15(1):73-76. PubMed ID: 31660841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
